US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Elixir Pharmaceuticals (MM) (ELXR) 銘柄情報

Elixir Pharmaceuticals (MM) (ELXR)

0.00

0.00

(0.00%)

終了 6月24日 5:00AM

0.00

0.00

(0.00%)

取引時間後: -

Elixir Pharmaceuticals (MM) (ELXR) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

-

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 0

発行済株式数

858,198

配当利回り

PER

-

1 株当たり利益 (EPS)

-29.17

歳入

35k

純利益

-21.15M

Elixir Pharmaceuticals, Inc. went out of business. Elixir Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes pharmaceuticals for the treatment of metabolic diseases. It develops small molecule drugs that mimic longevity responses, as well as used to treat a rang... Elixir Pharmaceuticals, Inc. went out of business. Elixir Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes pharmaceuticals for the treatment of metabolic diseases. It develops small molecule drugs that mimic longevity responses, as well as used to treat a range of age-related diseases, including diabetes and obesity. The company’s products include Metgluna and Glinsuna for the treatment of type 2 diabetes; Ghrelin, an oral antagonist for the treatment of metabolic diseases; and EX-1314, an oral drug developed for the treatment of type 1 diabetic gastroparesis. It has strategic alliances/partnerships with Kissei Pharmaceuticals, Bristol-Myers Squibb, Siena Biotech S.p.A., and Novartis Pharmaceuticals. The company was founded in 1999 and is headquartered in Cambridge, Massachusetts. 詳細を表示

セクター

-

業界

-

本社

Cambridge, United States

設立

1999

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ELXR - Frequently Asked Questions (FAQ)

What is the current Elixir Pharmaceuticals (MM) share price?

The current share price of Elixir Pharmaceuticals (MM) is US$ 0.00

How many Elixir Pharmaceuticals (MM) shares are in issue?

Elixir Pharmaceuticals (MM) has 858,198 shares in issue

What is the 1 year trading range for Elixir Pharmaceuticals (MM) share price?

Elixir Pharmaceuticals (MM) has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the registered address of Elixir Pharmaceuticals (MM)?

The registered address for Elixir Pharmaceuticals (MM) is 300 Putnam Avenue, Cambridge, Massachusetts, 02139

CA Market News

CA Market News 5分前

District Commences Drilling at the Österkälen Mineral License within the Alum Shale Properties in SwedenJune 24, 2026 2:00 AM
NewsfileV

US Market News

US Market News 5分前

Creating Shareholder Value Through a Possible SEGRO and Prologis CombinationJune 24, 2026 2:27 AM
PR Newswire (US) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO

snoopycomic

snoopycomic 6分前

Just give me $1.50

Just give me $1.50 18分前

NEW!!! -- ELITE PREPARING FOR NASDAQ LISTING

1. This is the first time in the HISTORY of Elite where they have now REMOVED any mention of third-party pharmaceutical organizations in the "About" section of Elite's press releases.

2. Elite has also REWORDED the "About"

theorysuit

theorysuit 20分前

And nwbo leadership is what fantastic. Lmfao. Can't even get a single approval in a sht small market let alone submit said reimbursement in said small market in nearly 3 years since they stumbled through submission and 6 years since data lock......fantastic nwbo leadership.. quite the accomplis

TaxHadas

TaxHadas 26分前

https://goodstrongink.com/cdn/shop/files/17942477570517511881_2048.jpg?v=1778971832&width=960

kazzy

We have big, smooth brains.

Pharma Sleuth

Pharma Sleuth 30分前

And another character speaks with a decade of trying to control dialogue. 10 posts in a row? And for what end? What is the requirement of this particular role? What is my take away from this scroll of repetition. What did I miss thats being pushed down? Or is it just a disturbance that attempt to di

Gristian

Gristian 34分前

Does that mean Cyberlux will not receive anything from the receivership? The money is completely allocated?

mrwrn2010

mrwrn2010 38分前

Why look at July 2025 when you can look at February 2026?

“Our next scheduled report is the 10-K report. That’s the annual report, and that report is due at the end of June. So I look forward to speaking with everyone then.”

TaxHadas

TaxHadas 44分前

the AITX + RAD + OMVS shell game fraud case

reality, facts, prosecution, names, dates , etc.

https://media.ca11.uscourts.gov/opinions/pub/files/202213129.pdf

-

Dodger1

Dodger1 50分前

Only a few, that is the goal...not a majority of people and their wishes...just for a few...Georgia GS

500 million that is all....HBAR knows i think, there might be a few more!

Most know population is on the decline for sure....just want to rub it in...make u feel guilt

Dodger1

Dodger1 53分前

interesting https:// www.youtube.com/watch?v=VMzPU7Bp9B0

Henk van vleuten

Henk van vleuten 57分前

https://x.com/juanosavin_/status/2069509374935023802/video/1?s=46

Trump also mentioned Nokia

rosemountbomber

rosemountbomber 59分前

I am in DRTS and agree that data looks great.

Werbe

Werbe 1時間前

Monti brought up some excellent info on David C. As for the patents, when you have an audit and they show no patents or assets attached to this ticker, that's enough 4 me.

norisknorewards

norisknorewards 1時間前

No big deal, just todays news release from UCLA to all prestigious Brown University Alumni. Nothing to see here...

Except the tidal wave building...

Henk van vleuten

Henk van vleuten 1時間前

This makes me happy

When we align the commercial timeline of Lightwave Logic (LWLG) with Nokia's expansion in Allentown, it creates a nearly seamless technological chain.Although LWLG is still in its pre-revenue phase (making the stock volatile), recent milestones from the first half

Henk van vleuten

Henk van vleuten 1時間前

The new production capacity at the Nokia factory in Allentown is expected to become commercially available by the end of the third quarter (late September).Important context to know:Existing Location: This is not a brand-new factory being built from the ground up, but rather a massive expansion and

Henk van vleuten

Henk van vleuten 1時間前

It is technologically and strategically very logical for Lightwave Logic (LWLG) to be directly or indirectly connected to these types of initiatives, although no direct, exclusive partnership with them is explicitly named in Nokia's official press releases regarding the Allentown facility.There are

AngeloFoca

AngeloFoca 1時間前

I still think the market cap valuation, if we are acquired at some point, would be around 23 billion. I’ve been saying that for many years.
I have also, for many years, expected a buyout at $23 billion, but now I think a buyout will come in 2 or 3 years, when DC-Vax Direct and EDEN have pro

amelia43

amelia43 1時間前

Not a word will be mentioned!

Last weekend Navy was tweeting that Trump was going to camp David over the weekend kind of suggesting something was going to happen to F2. Over the last 14 years I’ve read so many of these ridiculous posts hinting something was going to happen to F2. I

Just give me $1.50

Just give me $1.50 2時間前

It drops 94% of the time after Rat opens his big fat ugly incompetent mouth.

But what's really scary is we're starting at a baseline in the mid .30's

Recently, the price was much higher after Rat spoke allowing Elite to better sustain the near-guaranteed PPS collapse.

Just give me $1.50

Just give me $1.50 2時間前

Cool story bud...

2015 10-K - June 15 - Accelerated Filer
2016 10-K - June 15 - Accelerated Filer
2017 10-K - June 14 - Accelerated Filer
2018 10-K - June 14 - Accelerated Filer
2019 10-K - June 21 - Accelerated Filer (1 week delay - Notification

Investec Bnk 24

Annaly Capital Management

Metalo Manufacturing

Healthcare Administration Token

Bmo International Value ...

Domestic bond 0.5% 8oct2...

Euronext Euro Large Cap ...

ETFS Daily Short Nickel

Endeavour Mining (QX)

HSBC S&P 500 ETF

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。